U.S., Nov. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07238049) titled 'REAl World Dementia OUTcomes: Observational Study' on Sept. 01.
Brief Summary: READ-OUT observational study will investigate blood-based biomarkers for dementia in real-world clinical settings. This 3-year observational study will include 3165 people, males or females aged 45 years or older, with cognitive impairment of any severity.
Participants provide blood samples and complete questionnaires about quality of life and healthcare use, with some having additional follow-ups at 2 weeks and 1 year. The study will assess reliability and accuracy of blood tests in diagnosing dementia.
Study Start Date: Nov. 01, 2024
Study Type: OBSE...